ClinicalTrials.gg
RecruitingNCT07478341Updated Nov 18, 2026

Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding

An interventional study of Individualized Hybrid Breastfeeding Education in Breast Feeding, Exclusive Breast Feeding and Maternal-Fetal Attachment, sponsored by Emel GÜÇLÜ CİHAN. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Emel GÜÇLÜ CİHAN · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Nov 18, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Planned enrollment
185th of 252
64 · median 80
Started
2026
with 32 others
No phase
251 of 274
65 open now
Primary completion
2026-09
later than 52 of 76 live
Registered
212th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 185th largest by planned enrollment of the 252 interventional ones that give a count, is one of 33 that started in 2026, is one of 251 with no phase, reaches primary completion later than 52 of the 76 other live ones, and was the 212th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

68 of the 274 studies in Breast Feeding with a site in Turkey are open now. Recruiting first, the newest first:

62 more — sign in →

All 68 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years to 35 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled study aims to examine the effect of individualized hybrid breastfeeding education provided during late pregnancy on antenatal attachment and breastfeeding behaviors among first-time mothers. Participants will be randomly assigned to either the intervention or control group. Women in the intervention group will receive individualized hybrid breastfeeding education beginning at the 36th week of pregnancy. The program includes a face-to-face individual breastfeeding education session at 36 weeks of pregnancy and a reinforcement and practice session at 38 weeks. Participants will also have access to personalized digital educational materials, short educational videos, and online consultation support. In the postpartum period, participants will receive an online support session during the first week after birth and a follow-up session through online communication or telephone at the sixth postpartum week. The control group will receive routine hospital education during pregnancy. After completion of the study, the same educational materials will be provided to the control group in accordance with ethical principles. Data will be collected using the Demographic Information Form, Breastfeeding Behavior Evaluation Form, Antenatal Attachment Inventory, and Breastfeeding Self-Efficacy Scale. Written informed consent will be obtained from all participants prior to enrollment.

Read the detailed description

Maternal emotional attachment to the fetus during pregnancy is an important factor influencing breastfeeding success and the quality of mother-infant interaction in the postpartum period. Higher levels of antenatal attachment have been associated with earlier initiation of breastfeeding and stronger emotional bonding with the infant after birth. Educational and psychosocial interventions during pregnancy may therefore play an important role in strengthening the maternal-infant relationship and improving breastfeeding outcomes.

Breastfeeding is not only a nutritional practice but also a biological and psychosocial process that supports the development of secure attachment between mother and infant. Sustained breastfeeding contributes to maternal responsiveness and supports the infant's emotional security and development. First-time mothers often experience lower breastfeeding self-efficacy and may require additional professional guidance and support during the breastfeeding process.

Educational interventions implemented during pregnancy can enhance maternal knowledge, confidence, and emotional readiness for breastfeeding. Hybrid educational models that combine face-to-face and online approaches may increase accessibility while accommodating the physical and time limitations experienced during late pregnancy. Personalized digital educational materials and online counseling can further support mothers by providing flexible access to breastfeeding information and professional guidance.

However, studies examining individualized hybrid breastfeeding education programs initiated during the late stages of pregnancy for first-time mothers remain limited. Evaluating the effectiveness of such programs may contribute to improving antenatal attachment and promoting positive breastfeeding behaviors after birth.

Therefore, the purpose of this randomized controlled study is to evaluate the effect of individualized hybrid breastfeeding education initiated during late pregnancy (approximately at the 36th week of gestation) on antenatal attachment and breastfeeding behaviors among primiparous women.

03

Conditions studied

  • Breast Feeding
  • Exclusive Breast Feeding
  • Maternal-Fetal Attachment
  • Primiparity

Browse trials for

Keywords

  • Breastfeeding Education
  • Hybrid Education
  • Primiparous Women
  • Antenatal Attachment
  • Breastfeeding Self-Efficacy
  • Mother-Infant Bonding
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Aged 18-35 years,

At 36 weeks of gestation or later,

Experiencing their first pregnancy (primiparous),

Having a singleton pregnancy,

Able to read and write in Turkish and capable of communication,

Having access to a smartphone or the internet,

Free from any physical or mental health problems that would prevent participation in the education,

Willing to voluntarily participate in the study and provide written .

Exclusion criteria

Exclusion Criteria:

Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes),

Multiple pregnancy,

Gestation earlier than 36 weeks,

Inability to actively participate in the education due to communication barriers or cognitive impairment,

Lack of access to a smartphone or the internet,

Failure to attend any stage of the educational program or voluntary withdrawal from the study,

Refusal to participate in the study or failure to sign the form.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Intervention Group: Individualized Hybrid Breastfeeding Education

    Primiparous pregnant women in this group will receive an individualized hybrid breastfeeding education program planned for late pregnancy. The education includes both face-to-face and online components and covers content designed to support breastfeeding knowledge, skills, and mother-infant attachment.

    Behavioral: Individualized Hybrid Breastfeeding Education

  • No intervention
    Control Group: Standard Prenatal Care

    Primiparous pregnant women in this group will not receive any additional intervention during the study period; they will receive routine prenatal care and standard informational services.

Interventions

  • BehavioralIndividualized Hybrid Breastfeeding Education

    Primiparous pregnant women in the intervention group will receive an individualized hybrid breastfeeding education program planned for late pregnancy. The education consists of a hybrid structure including face-to-face sessions and online educational materials. The content covers the importance of breastfeeding, breastfeeding techniques, common breastfeeding problems, approaches to support mother-infant attachment, and preparation for the postpartum breastfeeding process. The intervention will be provided in addition to standard prenatal care.

    Also known as: Standard Prenatal Care

06

What researchers measure

Primary outcomes

  1. Antenatal Maternal Attachment

    The level of antenatal maternal attachment will be assessed using the Maternal Antenatal Attachment Scale (MAAS). The scale consists of 19 items rated on a 5-point Likert scale. Total scores range from 19 to 95, with higher scores indicating stronger antenatal maternal attachment.

    Time frame: 36-38 weeks of pregnancy

Secondary outcomes

  1. Breastfeeding Self-Efficacy

    Breastfeeding self-efficacy will be assessed using the Breastfeeding Self-Efficacy Scale (BSES). The scale consists of 33 items rated on a 5-point Likert scale. Total scores range from 33 to 165, with higher scores indicating greater breastfeeding self-efficacy.

    Time frame: At 1 and 6 weeks postpartum

07

Study locations

1 of 1 sites recruiting
  • Elbistan Devlet Hastanesi
    Elbistan, Kahramanmaraş 46040, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) from this study will not be shared with other researchers. To protect participant confidentiality, the data will be analyzed solely by the research team and will not be shared with third parties.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Sep 2026, 1 month.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 1 month is below that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Jan 2026 → Jul 2026, primary completion Jun 2026 → Sep 2026 and completion Sep 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2026
First posted
Mar 17, 2026
StartActual
Jul 23, 2026was Jan 2026
Primary completionActual
Sep 12, 2026was Jun 2026
CompletionEst.
Dec 30, 2026was Sep 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jan 30, 2026→Jul 23, 2026
Nov 18, 2026
Primary completion
Jun 14, 2026→Sep 12, 2026
Nov 18, 2026
Study completion
Sep 30, 2026→Dec 30, 2026
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Start date Jan 30, 2026→Jul 23, 2026
    Primary completion Jun 14, 2026→Sep 12, 2026
    Study completion Sep 30, 2026→Dec 30, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07478341
Lead sponsor
Emel GÜÇLÜ CİHAN
Responsible party
Emel GÜÇLÜ CİHAN (Assistant Professor, PhD, Kahramanmaras Sutcu Imam University) — Sponsor-investigator
First posted
Mar 17, 2026
Start date
Jul 23, 2026
Primary completion
Sep 12, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Nov 18, 2026

Study contacts

Asst. Prof.
Contact
emel_guclu4606@hotmail.com
3443004901
Asst. Prof.
principal investigator · Kahramanmaras Sutcu Imam University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion